
In a breakthrough study, researchers from University of the Mediterranean, France, have discovered a new virus that can infect other viruses - and can be used to combat viral infections,
The research team led by Didier Raoult have found a new virus called Sputnik that spreads by hijacking the replication machinery of the mamavirus- a new strain of the giant mimivirus.
Advertisement
Owing to its similarities to bacteriophages or phages, viruses that infect bacteria, the new class of virus has been dubbed as 'virophage', as the one virus invades another.
The team found that Sputnik could reduce the spread of mamavirus in amoeba and also acquired genes from other viruses.
The new finding can open up new avenues of understanding the genetic evolution of harmful viruses and use virophages to destroy them.
"It's too early to say we could use Sputnik as a weapon against big viruses or to modify them," New Scinetist quoted co-author Bernard La Scola, also at the University of the Mediterranean, as saying.
"But phages are used to modify bacteria, so why not?" he added.
"What is interesting here is that Sputnik is doing this at the expense of the bigger virus," said Robin Weiss, of University College London.
The findings appear in journal Nature.
Source: ANI
SPH
The new finding can open up new avenues of understanding the genetic evolution of harmful viruses and use virophages to destroy them.
Advertisement
"It's too early to say we could use Sputnik as a weapon against big viruses or to modify them," New Scinetist quoted co-author Bernard La Scola, also at the University of the Mediterranean, as saying.
"But phages are used to modify bacteria, so why not?" he added.
"What is interesting here is that Sputnik is doing this at the expense of the bigger virus," said Robin Weiss, of University College London.
The findings appear in journal Nature.
Source: ANI
SPH
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News

South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.

Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.

By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.

Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.

Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.